Why Is Tango Therapeutics Stock Soaring Monday?

Tango Therapeutics, Inc. (NASDAQ:TNGX) stock is up during Monday’s premarket session as the company announced positive initial data from its ongoing Phase 1/2 trial involving vopimetostat and daraxonrasib. The results indicate a 90% progression-free survival rate at...